Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luna Prieto Garcia

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The AAPS Journal|October 6, 2025
Integrated Physiologically-Based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population. Part 1: Model Development and ValidationLuna Prieto Garcia, Pär Nordell, Christine Ahlström, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 27, 2017
Intrinsic Clearance Assay Incubational Binding: A Method ComparisonSofia Chen, Luna Prieto Garcia, Fredrik Bergström, et al.
Psychoneuroendocrinology|September 24, 2015
Ghrelin and GHS-R1A signaling within the ventral and laterodorsal tegmental area regulate sexual behavior in sexually naïve male miceLuna Prieto-Garcia, Emil Egecioglu, Erik Studer, et al.
Addiction Biology|December 6, 2014
The role of ghrelin signalling for sexual behaviour in male miceEmil Egecioglu, Luna Prieto-Garcia, Erik Studer, et al.
The AAPS Journal|October 31, 2025
Integrated Physiologically-based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population. Part 2: MIDD and MIPD ApplicationsLuna Prieto Garcia, Pär Nordell, Christine Ahlström, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 20, 2022
Does the choice of applied physiologically-based pharmacokinetics platform matter? A case study on simvastatin disposition and drug-drug interactionLuna Prieto Garcia, Anna Lundahl, Christine Ahlström, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 3, 2018
Physiologically Based Pharmacokinetic Model of Itraconazole and Two of Its Metabolites to Improve the Predictions and the Mechanistic Understanding of CYP3A4 Drug-Drug InteractionsLuna Prieto Garcia, David Janzén, Kajsa P Kanebratt, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 5, 2024
Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statinsLuna Prieto Garcia, Anna Vildhede, Pär Nordell, et al.
Clinical Pharmacology and Therapeutics|June 28, 2023
Understanding Statin-Roxadustat Drug-Drug-Disease Interaction Using Physiologically-Based Pharmacokinetic ModelingJin Dong, Luna Prieto Garcia, Yingbo Huang, et al.
Clinical Pharmacology and Therapeutics|September 24, 2020
Proteomics-Informed Prediction of Rosuvastatin Plasma Profiles in Patients With a Wide Range of Body WeightChristine Wegler, Luna Prieto Garcia, Signe Klinting, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The AAPS Journal|October 6, 2025
Integrated Physiologically-Based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population. Part 1: Model Development and ValidationLuna Prieto Garcia, Pär Nordell, Christine Ahlström, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 27, 2017
Intrinsic Clearance Assay Incubational Binding: A Method ComparisonSofia Chen, Luna Prieto Garcia, Fredrik Bergström, et al.
Psychoneuroendocrinology|September 24, 2015
Ghrelin and GHS-R1A signaling within the ventral and laterodorsal tegmental area regulate sexual behavior in sexually naïve male miceLuna Prieto-Garcia, Emil Egecioglu, Erik Studer, et al.
Addiction Biology|December 6, 2014
The role of ghrelin signalling for sexual behaviour in male miceEmil Egecioglu, Luna Prieto-Garcia, Erik Studer, et al.
The AAPS Journal|October 31, 2025
Integrated Physiologically-based Pharmacokinetic Model with a Quantitative Systems Pharmacology and Toxicology Model for Statins in Disease Population. Part 2: MIDD and MIPD ApplicationsLuna Prieto Garcia, Pär Nordell, Christine Ahlström, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 20, 2022
Does the choice of applied physiologically-based pharmacokinetics platform matter? A case study on simvastatin disposition and drug-drug interactionLuna Prieto Garcia, Anna Lundahl, Christine Ahlström, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 3, 2018
Physiologically Based Pharmacokinetic Model of Itraconazole and Two of Its Metabolites to Improve the Predictions and the Mechanistic Understanding of CYP3A4 Drug-Drug InteractionsLuna Prieto Garcia, David Janzén, Kajsa P Kanebratt, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 5, 2024
Physiologically based pharmacokinetics modeling and transporter proteomics to predict systemic and local liver and muscle disposition of statinsLuna Prieto Garcia, Anna Vildhede, Pär Nordell, et al.
Clinical Pharmacology and Therapeutics|June 28, 2023
Understanding Statin-Roxadustat Drug-Drug-Disease Interaction Using Physiologically-Based Pharmacokinetic ModelingJin Dong, Luna Prieto Garcia, Yingbo Huang, et al.
Clinical Pharmacology and Therapeutics|September 24, 2020
Proteomics-Informed Prediction of Rosuvastatin Plasma Profiles in Patients With a Wide Range of Body WeightChristine Wegler, Luna Prieto Garcia, Signe Klinting, et al.
Pageof 2